NBIX Exercise Disclosure
Benevich Eric · SEC Form 4 · Filed Sep 10, 2026
Exercise
Calculated transaction value
$138.11K
Benevich Eric Chief Commercial Officer
NBIX
Transaction date
Sep 9, 2026
Public filing date
Sep 11, 2026
Filing lag
Filed 2 days later
NBIX daily price context
Close on/before transaction
$155.14
Sep 9, 2026
Close before public filing
$156.57
Sep 10, 2026
Return since public filing
-0.22%
Through Sep 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 3,194 shares @ $43.24
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001643653-26-000016
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$471.14K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Neurocrine Biosciences Inc NBIX Current | Exercise | Sep 9, 2026 | $138.11K |
| Neurocrine Biosciences Inc NBIX | Sale | Sep 9, 2026 | $333.03K |
| Neurocrine Biosciences Inc NBIX | Exercise | Sep 9, 2026 | $0 |